CGA (Gene)

Organism:

Homo sapiens

Synonyms:CG-ALPHA, CGA, ENTREZ:1081, FSHA, GPA1, GPHA1, GPHa, HCG, HGNC:1885, LHA, MIM:118850, NM_000735, NM_001252383, NP_000726, NP_001239312, TSHA, glycoprotein hormones, alpha polypeptide

Omim:OMIM:118850

Id:f312d68e-4515-58da-97f0-4ed03dc9bcb2

Hgnc:HGNC:1885

Entrez:1081

Ensembl:ENSG00000135346

Description:glycoprotein hormones, alpha polypeptide

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CGA's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CGA.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CGA.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CGA.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CGA.

Results found

Linked to

	Label	Description
	GSE248770 STIM1 knockout Hep 3B2.1-7 Sorafenib 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE248770 sorafenib Hep 3B2.1-7 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE151412 sorafenib 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE221329 ERK BRAF inhibition thyroid gland 3 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE226525 GSE226527 HNRNPH2 knockout 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 5 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE203329 HCC knockout 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 0 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE165548 gemcitabine 2 v 13 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225375 CDK12 CDK13 inhibition 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE248770 STIM1 knockout Hep 3B2.1-7 Sorafenib 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE248770 sorafenib Hep 3B2.1-7 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE151412 sorafenib 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE221329 ERK BRAF inhibition thyroid gland 3 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE226525 GSE226527 HNRNPH2 knockout 4 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE226249 pirfenidone HL 5 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE203329 HCC knockout 2 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE226249 pirfenidone HL 0 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE165548 gemcitabine 2 v 13 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE225375 CDK12 CDK13 inhibition 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.